PGS.TS Phạm Văn Thái

Hồ sơ 7/10

19 công bố · 25 trích dẫn · h-index 3

Thông tin

🏛️Nơi công tác: Trường Đại học Y Hà Nội
🔬Lĩnh vực: Y - Dược
🆔ORCID: 0009-0005-3073-8406
🎂Năm sinh: 1978
🏅Đạt chuẩn PGS 2025
✍️Hồ sơ chưa đầy đủ — bổ sung thông tin

Nguồn dữ liệu: Nguồn: HĐGSNN — Danh sách đạt chuẩn chức danh GS, PGS năm 2025 (Phiên họp IV, 11/2025). Thông tin tổng hợp từ nguồn công khai chính danh; học giả có toàn quyền nhận, bổ sung hoặc yêu cầu gỡ hồ sơ.

Công bố tiêu biểu

BRCA mutation in Vietnamese prostate cancer patients: a mixed cross-sectional study and case series5 trích dẫn
ONCOLOGIE · 2024 · DOI

The Effectiveness of Afatinib as First‐Line Treatment in Vietnamese Patients With EGFR‐Mutant Non–Small Cell Lung Cancer and Brain Metastases3 trích dẫn
Asia-Pacific Journal of Clinical Oncology · 2024 · DOI

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam3 trích dẫn
Therapeutic Advances in Medical Oncology · 2024 · DOI

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam3 trích dẫn
BMC Cancer · 2024 · DOI

Efforts in the Formation and Development of Nuclear Medicine in Vietnam2 trích dẫn
Nuclear Medicine and Molecular Imaging · 2019 · DOI

Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study2 trích dẫn
Asian Pacific Journal of Cancer Prevention · 2024 · DOI

Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam1 trích dẫn
Therapeutic Advances in Medical Oncology · 2025 · DOI

A Real-World Cohort Study of First-Line Afatinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer in Vietnam1 trích dẫn
Research Square · 2023 · DOI

Author response for "Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam"
· 2025 · DOI

A case report of sarcomatoid hepatocellular carcinoma treated multimodality
Advances in Radiotherapy & Nuclear Medicine · 2025 · DOI

Về lĩnh vực Y - Dược

6.619học giả

91.896công bố

2.589.484trích dẫn

4.2h-index trung bình

Hướng nghiên cứu phổ biến trong lĩnh vực:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Nơi có nhiều học giả lĩnh vực này nhất: